Mouse models in atherosclerosis

Drug Discovery Today: Disease Models

Volumn 5, Issue 3, 2008, Pages 157-163

  deLuna, Andres ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER A1; ABC TRANSPORTER G1; APELIN; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 1; APOLIPOPROTEIN B100; APOLIPOPROTEIN B48; APOLIPOPROTEIN C1; APOLIPOPROTEIN E; APOLIPOPROTEIN E3; CD137 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; CHOLESTEROL ESTER TRANSFER PROTEIN INHIBITOR; HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; MULTIDRUG RESISTANCE PROTEIN 1; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; RAG1 PROTEIN; RAG2 PROTEIN; RANTES; RENIN; STROMAL CELL DERIVED FACTOR 1; VERY LOW DENSITY LIPOPROTEIN;

ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; DIET SUPPLEMENTATION; DISEASE MODEL; DYSLIPIDEMIA; GENE OVEREXPRESSION; GENE TARGETING; GENETIC ASSOCIATION; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; NONHUMAN; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; UNSTABLE ANGINA PECTORIS;

EID: 67651208855     PISSN: 17406757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmod.2009.03.007     Document Type: Review

References (50)

1. Silver L. Mouse Genetics: Concepts and Applications (1995), Oxford University Press
2. Xu Q. A Handbook of Mouse Models of Cardiovascular Disease (October 2006), Wiley
3. Zadelaar S., et al. Mouse models for atherosclerosis and pharmaceutical modifiers. Arterioscler. Thromb. Vasc. Biol. 27 (August 2007) 1706-1721 (Epub 2007 May 31. Review)
4. Mayr M., et al. Proteomic and metabolomic analysis of smooth muscle cells derived from the arterial media and adventitial progenitors of apolipoprotein E-deficient mice. Circ. Res. 102 (May 2008) 1046-1056 (Epub 2008 April 3)
5. Hofker M.H., et al. Transgenic mouse models to study the role of APOE in hyperlipidemia and atherosclerosis. Atherosclerosis 137 (March 1998) 1-11 (Review)
6. Getz G.S., and Reardon C.A. Diet and murine atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 26 (February 2006) 242-249 (Epub 2005 December 22. Review)
7. Araujo J.A., et al. Ambient particulate pollutants in the ultrafine range promote early atherosclerosis and systemic oxidative stress. Circ. Res. 102 (March 2008) 589-596 (Epub 2008 January 17)
8. Chun H.J., et al. Apelin signaling antagonizes Ang II effects in mouse models of atherosclerosis. J. Clin. Invest. 118 (October 2008) 3343-3354
9. Olofsson P.S., et al. CD137 is expressed in human atherosclerosis and promotes development of plaque inflammation in hypercholesterolemic mice. Circulation 117 (March 2008) 1292-1301 (Epub 2008 February 19)
10. Lu H., et al. Renin inhibition reduces hypercholesterolemia-induced atherosclerosis in mice. J. Clin. Invest. 118 (March 2008) 984-993
11. Kolovou Kolovou G., et al. Apolipoprotein E knockout models. Curr. Pharm. Des. 14 (2008) 338-351 (Review)
12. Zhang W.J., et al. Dietary alpha-lipoic acid supplementation inhibits atherosclerotic lesion development in apolipoprotein E-deficient and apolipoprotein E/low-density lipoprotein receptor-deficient mice. Circulation 117 (January 2008) 421-428 (Epub 2007 December 24)
13. Navab M., et al. Apolipoprotein A-I mimetic peptides and their role in atherosclerosis prevention. Nat. Clin. Pract. Cardiovasc. Med. 3 (October 2006) 540-547 (Review)
14. Schiopu A., et al. Recombinant antibodies to an oxidized low-density lipoprotein epitope induce rapid regression of atherosclerosis in apobec-1(-/-)/low-density lipoprotein receptor(-/-) mice. J. Am. Coll. Cardiol. 50 (December 2007) 2313-2318 (Epub 2007 November 26)
15. Caligiuri G., et al. Phosphorylcholine-targeting immunization reduces atherosclerosis. J. Am. Coll. Cardiol. 50 (August 2007) 540-546 (Epub 2007 July 23)
16. de Haan W., et al. Torcetrapib does not reduce atherosclerosis beyond atorvastatin and induces more proinflammatory lesions than atorvastatin. Circulation 117 (May 2008) 2515-2522 (Epub 2008 May 5)
17. Barish G.D., et al. PPARdelta regulates multiple proinflammatory pathways to suppress atherosclerosis. Proc. Natl. Acad. Sci. U.S.A. 105 (March 2008) 4271-4276 (Epub 2008 March 12)
18. Takata Y., et al. PPARdelta-mediated antiinflammatory mechanisms inhibit angiotensin II-accelerated atherosclerosis. Proc. Natl. Acad. Sci. U.S.A. 105 (March 2008) 4277-4282 (Epub 2008 March 12)
19. Mueller C.F., et al. Multidrug resistance protein-1 affects oxidative stress, endothelial dysfunction, and atherogenesis via leukotriene C4 export. Circulation 117 (June 2008) 2912-2918 (Epub 2008 May 27)
20. Braunersreuther V., et al. A novel RANTES antagonist prevents progression of established atherosclerotic lesions in mice. Arterioscler. Thromb. Vasc. Biol. 28 (June 2008) 1090-1096 (Epub 2008 Apr 3)
21. von zur Muhlen C., et al. Magnetic resonance imaging contrast agent targeted toward activated platelets allows in vivo detection of thrombosis and monitoring of thrombolysis. Circulation 118 (July 2008) 258-267 (Epub 2008 June 23)
22. Briley-Saebo K.C., et al. Targeted molecular probes for imaging atherosclerotic lesions with magnetic resonance using antibodies that recognize oxidation-specific epitopes. Circulation 117 (June 2008) 3206-3215 (Epub 2008 June 9)
23. Lancelot E., et al. Evaluation of matrix metalloproteinases in atherosclerosis using a novel noninvasive imaging approach. Arterioscler. Thromb. Vasc. Biol. 28 (March 2008) 425-432 (Epub 2008 February 7)
24. McAteer M.A., et al. Magnetic resonance imaging of endothelial adhesion molecules in mouse atherosclerosis using dual-targeted microparticles of iron oxide. Arterioscler. Thromb. Vasc. Biol. 28 (January 2008) 77-83 (Epub 2007 October 25)
25. Nahrendorf M., et al. Nanoparticle PET-CT imaging of macrophages in inflammatory atherosclerosis. Circulation 117 (January 2008) 379-387 (Epub 2007 December 24)
26. Kircher M.F., et al. Noninvasive in vivo imaging of monocyte trafficking to atherosclerotic lesions. Circulation 117 (January 2008) 388-395 (Epub 2008 Jan 2)
27. McMahon A.C., et al. Animal models of atherosclerosis progression: current concepts. Curr. Drug Targets Cardiovasc. Haematol. Disord. 5 (December 2005) 433-440 (Review)
28. Jackson C.L., et al. Assessment of unstable atherosclerosis in mice. Arterioscler. Thromb. Vasc. Biol. 27 (April 2007) 714-720 (Epub 2007 March 1. Review)
29. Schwartz S.M., et al. Plaque rupture in humans and mice. Arterioscler. Thromb. Vasc. Biol. 27 (April 2007) 705-713 (Epub 2007 Mar 1. Review)
30. Westrick R.J., et al. Murine models of vascular thrombosis (Eitzman series). Arterioscler. Thromb. Vasc. Biol. 27 (October 2007) 2079-2093 (Epub 2007 June 28. Review)
31. Verbeuren T.J. Experimental models of thrombosis and atherosclerosis. Therapie 61 (September-October 2006) 379-387 (Review)
32. Getz G.S., et al. The immune system and murine atherosclerosis. Curr. Drug Targets 8 (December 2007) 1297-1306 (Review)
33. Wu K.K., and Huan Y. Diabetic atherosclerosis mouse models. Atherosclerosis 191 (April 2007) 241-249 (Epub 2006 September 18. Review)
34. Harja E., et al. Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE-/- mice. J. Clin. Invest. 118 (January 2008) 183-194
35. Hechler B., et al. Reduced atherosclerotic lesions in P2Y1/apolipoprotein E double-knockout mice: the contribution of non-hematopoietic-derived P2Y1 receptors. Circulation 118 (August 2008) 754-763 (Epub 2008 July 28)
36. Teupser D., et al. Effect of macrophage overexpression of murine liver X receptor-alpha (LXR-alpha) on atherosclerosis in LDL-receptor deficient mice. Arterioscler. Thromb. Vasc. Biol. 28 (November 2008) 2009-2015 (Epub 2008 September 11. PMID: 18787185 [PubMed - indexed for MEDLINE])
37. Yvan-Charvet L., et al. Combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in mice. J. Clin. Invest. 117 (December 2007) 3900-3908
38. Combadière C., et al. Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6C(hi) and Ly6C(lo) monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice. Circulation 117 (April 2008) 1649-1657 (Epub 2008 March 17)
39. Zernecke A., et al. Protective role of CXC receptor 4/CXC ligand 12 unveils the importance of neutrophils in atherosclerosis. Circ. Res. 102 (February 2008) 209-217 (Epub 2007 November 8)
40. Groyer E., et al. Atheroprotective effect of CD31 receptor globulin through enrichment of circulating regulatory T-cells. J. Am. Coll. Cardiol. 50 (July 2007) 344-350 (Epub 2007 July 6)
41. Su Y.R., et al. Lentiviral transduction of apoAI into hematopoietic progenitor cells and macrophages: applications to cell therapy of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 28 (August 2008) 1439-1446 (Epub 2008 May 22)
42. Ishigaki Y., et al. Impact of plasma oxidized low-density lipoprotein removal on atherosclerosis. Circulation 118 (July 2008) 75-83 (Epub 2008 June 16)
43. Zeng H., et al. An inducible and reversible mouse genetic rescue system. PLoS Genet. 4 (May 2008) e1000069
44. Holdt L.M., et al. Increased ADAM17 mRNA expression and activity is associated with atherosclerosis resistance in LDL-receptor deficient mice. Arterioscler. Thromb. Vasc. Biol. 28 (June 2008) 1097-1103 (Epub 2008 March 20)
45. Schadt E.E., et al. An integrative genomics approach to infer causal associations between gene expression and disease. Nat. Genet. 37 (July 2005) 710-717 (Epub 2005 June 19)
46. Meng H., et al. Identification of Abcc6 as the major causal gene for dystrophic cardiac calcification in mice through integrative genomics. Proc. Natl. Acad. Sci. U.S.A. 104 (March 2007) 4530-4535 (Epub 2007 March 6)
47. Kleemann R., et al. Atherosclerosis and liver inflammation induced by increased dietary cholesterol intake: a combined transcriptomics and metabolomics analysis. Genome Biol. 8 (2007) R200
48. Smith J.D., et al. Transcriptome profile of macrophages from atherosclerosis-sensitive and atherosclerosis-resistant mice. Mamm. Genome 17 (March 2006) 220-229 (Epub 2006 March 3)
49. Chen Y., et al. Variations in DNA elucidate molecular networks that cause disease. Nature 452 (March 2008) 429-435 (Epub 2008 March 16)
50. Schadt E.E., et al. Mapping the genetic architecture of gene expression in human liver. PLoS Biol. 6 (May 2008) e107